Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Blood Transfusion and Agglutination02:45

Blood Transfusion and Agglutination

15.1K
Blood transfusion is a therapeutic measure to restore the blood volume after extensive blood loss due to an accident or a medical procedure. Blood transfusion involves drawing a certain amount of blood from a suitable donor and infusing it into the recipient.
History
The history of blood transfusion dates back to the 17th century, when early attempts were made in animals. In 1818 James Blundell, a British doctor, performed the first successful human blood transfusion. Later in 1900, Karl...
15.1K
Blood Transfusion01:15

Blood Transfusion

2.5K
Blood transfusion is a critical medical procedure that saves lives and treats various medical conditions. It involves transferring blood from a donor to a recipient. This process requires a thorough understanding of the ABO blood group system and its associated antigens and antibodies.
Blood Transfusion Overview
A blood transfusion is a medical procedure used to replace blood lost due to injury, surgery, or to treat conditions such as anemia or cancer. During a transfusion, donor blood is...
2.5K
Bone Marrow Sampling and Transplants01:22

Bone Marrow Sampling and Transplants

1.7K
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
1.7K
Tissue Transplantation01:24

Tissue Transplantation

1.1K
Tissue transplantation is a significant medical procedure involving the transfer of cells, tissues, or organs from a donor to a recipient, with the primary aim of restoring lost functions. This procedure is crucial in treating a broad spectrum of diseases, including kidney diseases, liver failure, heart disease, and certain types of cancers.
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
1.1K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Monitoring and feedback using data in transfusion medicine: A study of practices from the BEST Collaborative.

Transfusion·2026
Same author

The clinical use of cryoprecipitate and fibrinogen concentrate: A scoping review.

Transfusion·2026
Same author

Narrative medicine-inspired pedagogy for pathology residency: One pathology and laboratory medicine residency program's experience creating and implementing a narrative medicine-inspired curriculum as a component of didactics.

Academic pathology·2026
Same author

Traumatic Hemorrhage in Older Adults: Can Psoas Muscle Sarcopenia Assist in Clinical Decision-Making and Resource Utilization?

A&A practice·2026
Same author

Designing and implementing a clinical decision support tool to improve compliance with NICU transfusions.

Journal of perinatology : official journal of the California Perinatal Association·2026
Same author

Use of platelets and the challenge of adherence to guidelines: Who, when and why?

British journal of haematology·2026
Same journal

Invasive urothelial carcinoma in association with surface low-grade papillary urothelial carcinoma: clinical and pathologic insights from a rare entity.

American journal of clinical pathology·2026
Same journal

CEACAM1 expression by immunohistochemistry in B-cell lymphomas and plasma cell myeloma.

American journal of clinical pathology·2026
Same journal

Comprehensive multicriteria life cycle assessment of biopsy processing in a surgical pathology department.

American journal of clinical pathology·2026
Same journal

Prognostic significance of Myb protein and its downstream target genes in lacrimal gland adenoid cystic carcinoma.

American journal of clinical pathology·2026
Same journal

Mismatch repair protein "nonclassic expression loss" pattern in colorectal cancer: an important staining pattern that is not well understood.

American journal of clinical pathology·2026
Same journal

Musculoskeletal pain in medical laboratory personnel: a cross-sectional study.

American journal of clinical pathology·2026
See all related articles

Related Experiment Video

Updated: Feb 23, 2026

Continuous Manual Exchange Transfusion for Patients with Sickle Cell Disease: An Efficient Method to Avoid Iron Overload
05:23

Continuous Manual Exchange Transfusion for Patients with Sickle Cell Disease: An Efficient Method to Avoid Iron Overload

Published on: March 14, 2017

20.5K

Building a New Transfusion Service.

John R Hess1, Brenda K Hayden2, Virginia G Cruz-Cody2

  • 1Department of Laboratory Medicine, University of Washington School of Medicine, Seattle.

American Journal of Clinical Pathology
|September 14, 2017
PubMed
Summary
This summary is machine-generated.

Harborview Medical Center established a hospital-based transfusion service (HBTS), improving blood component delivery, reducing costs, and enhancing patient care, education, and research.

Keywords:
Centralized transfusion serviceChanging transfusion useLaboratory medical scientist educationPathology resident educationPatient blood managementRegional blood systems

More Related Videos

A Precision Medicine Tool for Measurement and Monitoring of Hemoglobin S in Sickle Cell Disease Patients Receiving Transfusion Therapy
07:24

A Precision Medicine Tool for Measurement and Monitoring of Hemoglobin S in Sickle Cell Disease Patients Receiving Transfusion Therapy

2.0K
Author Spotlight: Advancements in CAR-T Cell Manufacturing and Gene Therapy Production
06:18

Author Spotlight: Advancements in CAR-T Cell Manufacturing and Gene Therapy Production

Published on: August 18, 2023

3.8K

Related Experiment Videos

Last Updated: Feb 23, 2026

Continuous Manual Exchange Transfusion for Patients with Sickle Cell Disease: An Efficient Method to Avoid Iron Overload
05:23

Continuous Manual Exchange Transfusion for Patients with Sickle Cell Disease: An Efficient Method to Avoid Iron Overload

Published on: March 14, 2017

20.5K
A Precision Medicine Tool for Measurement and Monitoring of Hemoglobin S in Sickle Cell Disease Patients Receiving Transfusion Therapy
07:24

A Precision Medicine Tool for Measurement and Monitoring of Hemoglobin S in Sickle Cell Disease Patients Receiving Transfusion Therapy

2.0K
Author Spotlight: Advancements in CAR-T Cell Manufacturing and Gene Therapy Production
06:18

Author Spotlight: Advancements in CAR-T Cell Manufacturing and Gene Therapy Production

Published on: August 18, 2023

3.8K

Area of Science:

  • Transfusion Medicine
  • Hospital Administration
  • Laboratory Science

Background:

  • Harborview Medical Center (HMC) historically relied on a regional blood supplier for blood components and testing for over 60 years.
  • In 2011, HMC transitioned to a hospital-based transfusion service (HBTS).

Purpose of the Study:

  • To evaluate the impact of the hospital-based transfusion service (HBTS) after five years of operation.
  • To assess changes in blood use, quality, delivery times, costs, and educational outcomes.

Main Methods:

  • Retrospective review of hospital blood use, quality system events, delivery times, and costs from 2003 to 2015.
  • Evaluation of the effects on laboratory medicine resident and medical laboratory scientist student training.
  • Review of regulatory and accrediting agency concerns.

Main Results:

  • Significant reductions in blood component procurement, allocation, transfusion, and wastage.
  • Decreased costs associated with the transition to HBTS.
  • Reduced turnaround time for thawed plasma delivery to trauma patients from 90 to 3 minutes.
  • Improved transfusion medicine education metrics and $2 million in research funding.

Conclusions:

  • HMC successfully implemented an HBTS, providing high-quality transfusion support to a Level 1 trauma center.
  • The transition yielded near-term benefits in patient care, medical education, and research.
  • The HBTS resulted in faster, safer, and more cost-effective blood support.